Cargando…

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Han, Xiaofeng, Du, Fangfang, Jiang, Li, Zhu, Yifei, Chen, Zhen, Liu, Yanjun, Hong, Tingting, Wang, Teng, Mao, Yong, Wu, Xiaohong, Bruce, Iain C., Jin, Jian, Ma, Xin, Hua, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533660/ https://www.ncbi.nlm.nih.gov/pubmed/36276490 http://dx.doi.org/10.3892/ol.2022.13526

Ejemplares similares

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties
por: HAN, XIAOFENG, et al.
Publicado: (2013)

Effects of Adenosine on Apoptosis of Ovarian Cancer A2780 Cells via ROS and Caspase Pathways [Corrigendum]
Publicado: (2020)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88
por: Zhan, Yueping, et al.
Publicado: (2015)

Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)
por: Chiappetta, Giovanni, et al.
Publicado: (2022)

Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells
por: Fan, Li-li, et al.
Publicado: (2020)

Identification of upregulated exosomal miRNAs between A2780 and A2780/DDP human ovarian cancer cells by high-throughput sequencing
por: Wang, Huihui, et al.
Publicado: (2023)

Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp
por: Zhao, Ran, et al.
Publicado: (2017)

Corrigendum to “Cell therapies in ovarian cancer”
Publicado: (2021)

Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
por: Viscarra, Tamara, et al.
Publicado: (2019)

Effect of the HDAC Inhibitor on Histone Acetylation and Methyltransferases in A2780 Ovarian Cancer Cells
por: Natarajan, Umamaheswari, et al.
Publicado: (2021)

Investigation of Anticancer Properties of Monoterpene-Aminopyrimidine Hybrids on A2780 Ovarian Cancer Cells
por: Nagy, Viktória, et al.
Publicado: (2023)

Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death
por: Obiorah, I, et al.
Publicado: (2016)

Silencing of type Iγ phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion
por: Cao, Siyu, et al.
Publicado: (2021)

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells
por: Wang, Yifei, et al.
Publicado: (2022)

Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway
por: Zhang, Ke, et al.
Publicado: (2021)

Effects Of Adenosine On Apoptosis Of Ovarian Cancer A2780 Cells Via ROS And Caspase Pathways
por: Xia, Bing, et al.
Publicado: (2019)

Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer
por: Wang, Luqing, et al.
Publicado: (2017)

Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice
por: Chen, Xi, et al.
Publicado: (2016)

Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
por: Januchowski, Radosław, et al.
Publicado: (2014)

Cytotoxic Effects of Strawberry, Korean Raspberry, and Mulberry Extracts on Human Ovarian Cancer A2780 Cells
por: Lee, Dahae, et al.
Publicado: (2016)

Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway
por: Pfankuchen, Daniel Bastian, et al.
Publicado: (2017)

Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780)
por: Jafarzadeh, Samira, et al.
Publicado: (2021)

Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

Allogenic natural killer cell immunotherapy of sizeable ovarian cancer: A case report
por: Xie, Silun, et al.
Publicado: (2017)

Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780
por: Engelke, Laura H., et al.
Publicado: (2016)

Polysaccharides isolated from Bangia fuscopurpurea induce apoptosis and autophagy in human ovarian cancer A2780 cells
por: Wu, Jingna, et al.
Publicado: (2021)

Lubeluzole Repositioning as Chemosensitizing Agent on Multidrug-Resistant Human Ovarian A2780/DX3 Cancer Cells
por: Viale, Maurizio, et al.
Publicado: (2022)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2007)

Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum]
Publicado: (2020)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
por: Chiorean, E Gabriela, et al.
Publicado: (2016)

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”
por: Wang, Hao, et al.
Publicado: (2021)

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]
Publicado: (2020)

LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells
por: Wei, Ye, et al.
Publicado: (2018)

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
por: Milone, M R, et al.
Publicado: (2014)

The synergistic cytotoxic effect of cisplatin and honey bee venom on human ovarian cancer cell line A2780cp
por: Alizadehnohi, Masoumehzaman, et al.
Publicado: (2012)

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
por: Guo, Jing, et al.
Publicado: (2021)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

Pleuromutilin Inhibits Proliferation and Migration of A2780 and Caov-3 Ovarian Carcinoma Cells and Growth of Mouse A2780 Tumor Xenografts by Down-Regulation of pFAK2
por: Zhang, Bo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u2i51ldbgdkk5krlmubd2i039c